Globe Life Inc. (GL)

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

Symbol: GL
Exchange: NYSE
Sector: Financial Services
Industry: Insurance - Life
Market cap: $15.28B
52 week range: 127.85 - 191.55

Valuation

Share price: $165.68 (close of 2026-10-02)
P/E (TTM): 10.84x
Price to book: 2.48x
Price to free cash flow: 12.40x
Enterprise value: $17.77B
Book value per share: $66.75

Price performance

Period	Change
1 day	-0.09%
5 days	-0.81%
1 month	-4.42%
3 months	-8.21%
6 months	+16.19%
Year to date	+18.46%
1 year	+18.82%
3 years	+52.69%
5 years	+83.54%
10 years	+159.32%
All time	+5754.42%

Members of Congress who disclosed GL trades

Lisa McClain · Alan Armstrong

Super investors holding GL

Richard Pzena (Pzena Investment Management) · Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates) · Tweedy Browne (Tweedy Browne Company LLC)

Profitability and growth

Return on equity: 19.44%
Return on assets: 3.77%
Net margin: 19.37%
EBITDA margin: 26.81%
Revenue growth: 3.74%
Net income growth: 8.45%
Free cash flow growth: -5.82%

Cash flow and balance sheet

Free cash flow yield (TTM): 8.07%
Net debt to EBITDA: 1.52x

Latest reported year

Period end: 2025-12-31
Fiscal year: 2025
Revenue: $5.99B
EBITDA: $1.61B
Net income: $1.16B
Earnings per share: $14.27
Interest expense: $141.22M
Shares outstanding: 81.38M

Income statement by year

Period end	Revenue	Gross profit	Net income	EPS
2025-12-31	$5.99B	-	$1.16B	$14.27
2024-12-31	$5.78B	-	$1.07B	$11.99
2023-12-31	$5.45B	$1.26B	$970.75M	$10.21
2022-12-31	$5.23B	$1.18B	$894.39M	$9.13
2021-12-31	$5.11B	$1.22B	$1.03B	$10.10
2020-12-31	$4.74B	$901.05M	$731.77M	$6.90
2019-12-31	$4.53B	$910.66M	$760.79M	$6.97
2018-12-31	$4.30B	$865.48M	$701.47M	$6.22
2017-12-31	$4.16B	$807.04M	$1.45B	$12.50
2016-12-31	$3.93B	$782.92M	$549.78M	$4.58

Margins and returns by year

Period end	Gross margin	Net margin	Return on equity	Return on capital
2025-12-31	-	19.37%	19.44%	-
2024-12-31	-	18.53%	20.18%	-
2023-12-31	23.13%	17.82%	21.64%	16.23%
2022-12-31	22.55%	17.11%	22.65%	16.82%
2021-12-31	23.77%	20.17%	51.46%	27.80%
2020-12-31	19.02%	15.45%	8.34%	7.23%
2019-12-31	20.11%	16.80%	10.43%	8.78%
2018-12-31	20.11%	16.30%	12.95%	10.74%
2017-12-31	19.42%	35.00%	23.34%	11.53%
2016-12-31	19.90%	13.97%	12.04%	9.99%

Cash and debt by year

Period end	Cash	Debt
2025-12-31	$459.42M	$2.32B
2024-12-31	$250.36M	$2.32B
2023-12-31	$184.90M	$1.63B
2022-12-31	$206.68M	$1.63B
2021-12-31	$161.31M	$1.55B
2020-12-31	$202.63M	$1.67B
2019-12-31	$114.22M	$1.35B
2018-12-31	$184.31M	$1.36B
2017-12-31	$245.63M	$1.13B
2016-12-31	$148.20M	$1.13B

Free cash flow by year

Period end	Free cash flow	Stock-based compensation
2025-12-31	$1.25B	$53.35M
2024-12-31	$1.33B	$40.12M
2023-12-31	$1.43B	$30.74M
2022-12-31	$1.39B	$35.65M
2021-12-31	$1.40B	$30.27M
2020-12-31	$1.43B	$35.89M
2019-12-31	$1.32B	$44.84M
2018-12-31	$1.23B	$39.79M
2017-12-31	$1.41B	$37.03M
2016-12-31	$1.37B	$26.33M

Dividend history

Most recent payment: 2026-07-06
Paid in the last twelve months: $1.20

Payment date	Dividend per share
2026-07-06	$0.33
2026-04-02	$0.33
2026-01-05	$0.27
2025-10-03	$0.27
2025-07-03	$0.27
2025-04-03	$0.27
2025-01-06	$0.24
2024-10-04	$0.24

Investor relations

Next earnings report

Next confirmed report: 2026-10-28
Consensus EPS estimate: $4.89

Past earnings dates

Reported	Fiscal period	EPS estimate
2026-07-22	Jun/2026	$3.67
2026-04-22	Mar/2026	$3.46
2026-02-04	Dec/2025	$3.44
2025-10-22	Sep/2025	$4.54
2025-07-23	Jun/2025	$3.25
2025-04-30	Mar/2025	$3.24
2025-02-05	Dec/2024	$3.10
2024-10-23	Sep/2024	$3.05

Filings and sources

Company website: home.globelifeinsurance.com
SEC filings: 10-K, 10-Q and 8-K on EDGAR
Earnings calendar: All upcoming reports

Similar companies

Prudential Financial Inc (PRU) · Aflac Inc (AFL) · MetLife Inc (MET) · Chubb Ltd (CB) · Progressive Corp (PGR) · Travelers Companies, Inc. (TRV) · Allstate Corp (ALL) · Arch Capital Group Ltd. (ACGL)

All Financial Services companies

Understanding these figures

Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades